Recipharm in New German Market Collaboration with FHS Unternehmensberatung
News Oct 16, 2013
FHS Unternehmensberatung and Recipharm Pharmaceutical Development AB based in Stockholm have announced that they have entered into a collaboration.
FHS Unternehmensberatung will sell and market Recipharm’s development services, including formulation development, analytical development, manufacture of clinical trial material and stability studies, to customers in Austria, Germany and Switzerland.
“I am very excited about this collaboration”, says Torkel Gren, Sales Director, Recipharm Pharmaceutical Development AB. “FHS Unternehmensberatung has through its owner Fritz H. Speck an excellent knowledge of the contract development business and a very valuable network in German speaking countries. I am convinced that this will help us to reach out to new customers”.
“I am deeply impressed by the capabilities, the excellent experience and the staff's extraordinary team spirit at Recipharm PD” says Fritz Speck, owner of FHS Unternehmensberatung.
Speck continued, “To me it seems quite clear, that especially clients in the German-speaking market could benefit a lot from the attractive opportunities and multilingual experience at Recipharm PD. I look forward to a successful and pleasant cooperation with the team.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018